BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24619413)

  • 1. The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells.
    Ma B; Wells A
    J Biol Chem; 2014 Apr; 289(16):11153-11161. PubMed ID: 24619413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer.
    Chen J; Wang F; Xu H; Chen D; Liu W; Wang J
    J BUON; 2019; 24(6):2531-2538. PubMed ID: 31983129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.
    Chao Y; Wu Q; Shepard C; Wells A
    Clin Exp Metastasis; 2012 Jan; 29(1):39-50. PubMed ID: 21964676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals.
    Zhang XL; Wang HS; Liu N; Ge LC
    Arch Biochem Biophys; 2015 Nov; 585():10-16. PubMed ID: 26363213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune profiling of human prostate epithelial cells determined by expression of p38/TRAF-6/ERK MAP kinases pathways.
    Bouraoui Y; Achour M; Royuela M; Oueslati R
    Kaohsiung J Med Sci; 2018 Mar; 34(3):125-133. PubMed ID: 29475459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.
    Chao YL; Shepard CR; Wells A
    Mol Cancer; 2010 Jul; 9():179. PubMed ID: 20609236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway.
    Kuo PL; Chen YH; Chen TC; Shen KH; Hsu YL
    J Cell Physiol; 2011 May; 226(5):1224-31. PubMed ID: 20945384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
    Tsai CC; Chou YT; Fu HW
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway.
    Che J; Chan ES; Cronstein BN
    Mol Pharmacol; 2007 Dec; 72(6):1626-36. PubMed ID: 17872970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells].
    Fan B; Wang G; Qi F; Li Z; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):656-61. PubMed ID: 22886216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.
    Yates CC; Shepard CR; Stolz DB; Wells A
    Br J Cancer; 2007 Apr; 96(8):1246-52. PubMed ID: 17406365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
    Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
    Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway.
    Li WH; Qiu Y; Zhang HQ; Tian XX; Fang WG
    PLoS One; 2015; 10(7):e0133165. PubMed ID: 26182292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
    Tyagi A; Sharma Y; Agarwal C; Agarwal R
    Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.